Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia

Neuropsychobiology

Volumn 65, Issue 1, 2012, Pages 1-11

  Pae, Chi Un ^a,c   Chiesa, Alberto ^b   Porcelli, Stefano ^b   Han, Changsu ^d   Patkar, Ashwin A ^a   Lee, Soo Jung ^c   Park, Moon Ho ^d   Serretti, Alessandro ^b   De Ronchi, Diana ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

BDNF; Bipolar disorder; Brain derived neurotrophic factor; Major depression; Schizophrenia

Indexed keywords

ALPRAZOLAM; AMISULPRIDE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BUSPIRONE; CLONAZEPAM; FLUOXETINE; LAMOTRIGINE; LITHIUM; LORAZEPAM; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; VENLAFAXINE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOSPITAL PATIENT; HUMAN; KOREA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; YOUNG MANIA RATING SCALE;

EID: 84980053687     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000327605     Document Type: Article

References (67)

1. Vicario-Abejon C, Owens D, McKay R, Segal M: Role of neurotrophins in central synapse formation and stabilization. Nat Rev Neurosci 2002; 3: 965-974. (Pubitemid 135715882)
2. Woo NH, Lu B: Regulation of cortical interneurons by neurotrophins: from development to cognitive disorders. Neuroscientist 2006; 12: 43-56. (Pubitemid 43122382)
3. Shintani F: Cytokines and neurotrophins in psychiatric disorders. Biomed Rev 1999; 10: 69-73.
4. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50: 260-265. (Pubitemid 32778442)
5. Angelucci F, Aloe L, Gruber SH, Fiore M, Mathe AA: Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions. Int J Neuropsychopharmacol 2000; 3: 13-25. (Pubitemid 30354448)
6. Groves JO: Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 2007; 12: 1079-1088. (Pubitemid 350191365)
7. Angelucci F, Brene S, Mathe AA: Bdnf in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005; 10: 345-352.
8. Post RM: Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 2007; 41: 979-990. (Pubitemid 47301944)
9. Ghosh A, Carnahan J, Greenberg ME: Requirement for BDNF in activity-dependent survival of cortical neurons. Science 1994; 263: 1618-1623. (Pubitemid 24128367)
10. Lindholm D, Carroll P, Tzimagiogis G, Thoenen H: Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins BDNF, NT-3 and NT- 4. Eur J Neurosci 1996; 8: 1452-1460. (Pubitemid 26239824)
11. Alderson RF, Alterman AL, Barde YA, Lindsay RM: Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 1990; 5: 297-306. (Pubitemid 20294980)
12. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM: BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991; 350: 230-232. (Pubitemid 21912205)
13. Eaton MJ, Whittemore SR: Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS. Exp Neurol 1996; 140: 105-114. (Pubitemid 26254892)
14. + toxicity: role of BDNF gene expression. Brain Res Mol Brain Res 1996; 41: 14-26.
15. Siuciak JA, Altar CA, Wiegand SJ, Lindsay RM: Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Res 1994; 633: 326-330. (Pubitemid 24021278)
16. Mamounas LA, Blue ME, Siuciak JA, Altar CA: Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 1995; 15: 7929-7939. (Pubitemid 26006900)
17. Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, Uzbay T, Goka E: Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1256-1260. (Pubitemid 44216065)
18. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM: Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-148. (Pubitemid 34258493)
19. Palomino A, Vallejo-Illarramendi A, Gonzalez- Pinto A, Aldama A, Gonzalez-Gomez C, Mosquera F, Gonzalez-Garcia G, Matute C: Decreased levels of plasma BDNF in firstepisode schizophrenia and bipolar disorder patients. Schizophr Res 2006; 86: 321-322. (Pubitemid 44234056)
20. Knable MB, Barci BM, Webster MJ, Meador- Woodruff J, Torrey EF: Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley neuropathology consortium. Mol Psychiatry 2004; 9: 609-620, 544. (Pubitemid 38850441)
21. Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H, Mahadik SP: Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: Correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol 2010; 13: 535-539.
22. Xiu MH, Hui L, Dang YF, Hou TD, Zhang CX, Zheng YL, Chen da C, Kosten TR, Zhang XY: Decreased serum BDNF levels in chronic institutionalized schizophrenia on longterm treatment with typical and atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 1508-1512.
23. Suarez BK, Duan J, Sanders AR, Hinrichs AL, Jin CH, Hou C, Buccola NG, Hale N, Weilbaecher AN, Nertney DA, Olincy A, Green S, Schaffer AW, Smith CJ, Hannah DE, Rice JP, Cox NJ, Martinez M, Mowry BJ, Amin F, Silverman JM, Black DW, Byerley WF, Crowe RR, Freedman R, Cloninger CR, Levinson DF, Gejman PV: Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3- p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet 2006; 78: 315-333. (Pubitemid 43157570)
24. Schumacher J, Jamra RA, Becker T, Ohlraun S, Klopp N, Binder EB, Schulze TG, Deschner M, Schmal C, Hofels S, Zobel A, Illig T, Propping P, Holsboer F, Rietschel M, Nothen MM, Cichon S: Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 2005; 58: 307-314. (Pubitemid 41133624)
25. Ribeiro L, Busnello JV, Cantor RM, Whelan F, Whittaker P, Deloukas P, Wong ML, Licinio J: The brain-derived neurotrophic factor rs6265 (val66met) polymorphism and depression in Mexican-Americans. Neuroreport 2007; 18: 1291-1293. (Pubitemid 47075599)
26. Licinio J, Dong C, Wong ML: Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response. Arch Gen Psychiatry 2009; 66: 488-497.
27. Lavebratt C, Aberg E, Sjoholm LK, Forsell Y: Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J Affect Disord 2010; 125: 249-255.
28. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM: The val66met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 2006; 27: 1834-1837.
29. Chen L, Lawlor DA, Lewis SJ, Yuan W, Abdollahi MR, Timpson NJ, Day IN, Ebrahim S, Smith GD, Shugart YY: Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:814-821.
30. Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH, Yu X, Wei J, Liu ZC, Liu Y, Tao M, Li HC, Li KQ, Hu J, Li M, Zhang KR, Ye DQ, Xu XP: Association of brain-derived neurotrophic factor genetic val66met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology 2010; 61: 71-78.
31. Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS: Brain-derived neurotrophic factor gene polymorphism (val66met) and citalopram response in major depressive disorder. Brain Res 2006; 1118: 176-182.
32. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ: Association study of a brain-derived neurotrophic- factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet 2003; 123B:19-22. (Pubitemid 37323258)
33. Kang R, Chang H, Wong M, Choi M, Park J, Lee H, Jung I, Joe S, Kim L, Kim S, Kim Y, Han C, Ham B, Lee H, Ko Y, Lee M, Lee M: Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression. J Psychopharmacol 2010; 24: 1755-1763.
34. Domschke K, Lawford B, Laje G, Berger K, Young R, Morris P, Deckert J, Arolt V, Mc- Mahon FJ, Baune BT: Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response. Int J Neuropsychopharmacol 2010; 13: 93-101.
35. Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Szczepankiewicz A, Hauser J: Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients. Pharmacogenomics 2008; 9: 1595-1603.
36. Rybakowski JK, Suwalska A, Skibinska M, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J: Response to lithium prophylaxis: Interaction between serotonin transporter and BDNF genes. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:820-823. (Pubitemid 47417214)
37. Rybakowski JK, Suwalska A, Skibinska M, Szczepankiewicz A, Leszczynska-Rodziewicz A, Permoda A, Czerski PM, Hauser J: Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 2005; 38: 166-170. (Pubitemid 41059223)
38. Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT: Meta-analysis reveals no association of the val66met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 2007; 17: 165-170. (Pubitemid 46716209)
39. Xu J, Liu Y, Wang P, Li S, Wang Y, Li J, Zhou D, Chen Z, Zhao T, Wang T, Xu H, Yang Y, Feng G, He L, Yu L: Positive association between the brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in the Han Chinese population. Am J Med Genet B Neuropsychiatr Genet 2010; 153: 275-279.
40. Qian L, Zhao J, Shi Y, Zhao X, Feng G, Xu F, Zhu S, He L: Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochem Biophys Res Commun 2007; 353: 738-743. (Pubitemid 46048732)
41. Rybakowski JK: Bdnf gene: Functional val66met polymorphism in mood disorders and schizophrenia. Pharmacogenomics 2008; 9: 1589-1593.
42. Hong CJ, Yu YW, Lin CH, Tsai SJ: An association study of a brain-derived neurotrophic factor val66met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 2003; 349: 206-208. (Pubitemid 37297813)
43. Kawashima K, Ikeda M, Kishi T, Kitajima T, Yamanouchi Y, Kinoshita Y, Okochi T, Aleksic B, Tomita M, Okada T, Kunugi H, Inada T, Ozaki N, Iwata N: BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis. Schizophr Res 2009; 112: 72-79.
44. Liu X, Xu Y, Jiang S, Cui D, Qian Y, Jiang K: Family-based association study between brain-derived neurotrophic factor gene and major depressive disorder of Chinese descent. Psychiatry Res 2009; 169: 169-172.
45. Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D, Henigsberg N, Barreto M, Placentino A, Dernovsek MZ, Schulze TG, Kalember P, Zobel A, Czerski PM, Larsen ER, Souery D, Giovannini C, Gray JM, Lewis CM, Farmer A, Aitchison KJ, McGuffin P, Craig I: Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 2009; 9: 225-233.
46. Muller DJ, de Luca V, Sicard T, King N, Strauss J, Kennedy JL: Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br J Psychiatry 2006; 189: 317-323. (Pubitemid 44606744)
47. Okada T, Hashimoto R, Numakawa T, Iijima Y, Kosuga A, Tatsumi M, Kamijima K, Kato T, Kunugi H: A complex polymorphic region in the brain-derived neurotrophic factor (BDNF) gene confers susceptibility to bipolar disorder and affects transcriptional activity. Mol Psychiatry 2006; 11: 695-703. (Pubitemid 43989816)
48. Xu MQ, St. Clair D, Feng GY, Lin ZG, He G, Li X, He L: BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine- induced extrapyramidal syndrome in the Chinese population. Pharmacogenet Genomics 2008; 18: 449-457. (Pubitemid 351769923)
49. Jonsson EG, Edman-Ahlbom B, Sillen A, Gunnar A, Kulle B, Frigessi A, Vares M, Ekholm B, Wode-Helgodt B, Schumacher J, Cichon S, Agartz I, Sedvall GC, Hall H, Terenius L: Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 924-933. (Pubitemid 43810174)
50. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20):22-33, quiz 34-57. (Pubitemid 29001829)
51. Montgomery S, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389. (Pubitemid 9136500)
52. Young R, Biggs J, Ziegler V, Meyer D: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435. (Pubitemid 9006756)
53. Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276. (Pubitemid 18039085)
54. Riedel M, Moller HJ, Obermeier M, Schennach- Wolff R, Bauer M, Adli M, Kronmuller K, Nickel T, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Seemuller F: Response and remission criteria in major depression - a validation of current practice. J Psychiatr Res 2010; 44: 1063-1068.
55. Hirschfeld RM, Keck PE Jr, Kramer M, Karcher K, Canuso C, Eerdekens M, Grossman F: Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, doubleblind, placebo-controlled trial. Am J Psychiatry 2004; 161: 1057-1065. (Pubitemid 38735992)
56. Leucht S, Davis JM, Engel RR, Kane JM, Wagenpfeil S: Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology 2007; 32: 1903-1910. (Pubitemid 47258518)
57. Perlis RH, Baker RW, Zarate CA, Jr., Brown EB, Schuh LM, Jamal HH, Tohen M: Olanzapine versus risperidone in the treatment of manic or mixed states in bipolar I disorder: a randomized, double-blind trial. J Clin Psychiatry 2006; 67: 1747-1753. (Pubitemid 44955156)
58. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR: Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441-449. (Pubitemid 40343909)
59. Flemenbaum A, Zimmermann RL: Interand intra-rater reliability of the brief psychiatric rating scale. Psychol Rep 1973; 32: 783-792.
60. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
61. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I: Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125: 279-284. (Pubitemid 33000466)
62. Cohen J: Statistical Power Analysis for the Behavioral Sciences. Hillsdale, Lawrence Erlbaum Associates, 1988.
63. Drago A, De Ronchi D, Serretti A: Incomplete coverage of candidate genes: a poorly considered bias. Curr Genomics 2007; 8: 476-483. (Pubitemid 351486278)
64. Sullivan PF: Spurious genetic associations. Biol Psychiatry 2007; 61: 1121-1126. (Pubitemid 46669468)
65. Goodyer IM, Croudace T, Dudbridge F, Ban M, Herbert J: Polymorphisms in BDNF (Val66Met) and 5-HTTLPR, morning cortisol and subsequent depression in at-risk adolescents. Br J Psychiatry 2010; 197: 365-371.
66. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM: Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234-239.
67. Zimmerman M, Mattia JI, Posternak MA: Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002; 159: 469-473. (Pubitemid 34184745)